Sintim, Herman O

Back to all technologies

Innovations

Innovation Title Categories Lead Inventor
Anti-Angiogenesis Compound Targets Laminin Receptor in Cancer Cells
2017-FIGU-67894
  1. Pharmaceuticals
  2. Medical/Health
Figueiredo, Marxa L
Antibacterial Agents Against Methicilin- and Vancomycin-Resistant Bacteria
2018-SINT-68199
  1. Biotechnology
  2. Medical/Health
Sintim, Herman O
Dual Kinase/Demethylase as Inhibitors of Proliferative Diseases
2017-SINT-67825
  1. Chemistry and Chemical Analysis
  2. Pharmaceuticals
Sintim, Herman O
Therapeutic for Acute Myeloid Leukemia and Other Cancers
2016-SINT-67603
  1. Chemistry and Chemical Analysis
  2. Medical/Health
Sintim, Herman O

Details

Dr. Herman O. Sintim is the Drug Discovery Professor of Chemistry - Organic Chemistry/Chemical Biology at Purdue University. He received his B.S. at the University College London and his Ph.D. from the University of Oxford. Dr. Sintim has received many awards over his career, including the Sigma Xi Distinguished Lecturer award in 2015, the Allen Angerio Award for Excellence in Faculty Mentorship in 2010, and the NSF Career Award in 2008, to name a few. His research interests include the discovery of new anticancer agents; the chemical biology of bacterial communication, virulence factors production, and biofilm formation; the discovery of new antibiotics with novel modes of action; the catalytic cycle of total syntheses of complex bioactive molecules and the discovery of new reaction methodologies; and new DNA nanostructures and machines for bioanalyte detection.

For additional information, visit Dr. Sintim's Purdue webpage: website: https://www.chem.purdue.edu/people/directory/faculty/details/118
or his Sintim Research Group website: https://sites.google.com/site/sintimgrouphomepage/